Dr Stock Pick HOT News & Alerts!

_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________

DrStockPick.com Watch List!

My Picks for Thursday October 8, 2009, are:

**************************************************************

WYN, Wyndham Worldwide Corporation

WYN provides various hospitality products and services to individual consumers and business customers. WYN’s Lodging segment franchises hotels in the upscale, middle, and economy segments of the lodging industry, as well as provides property management services to owners of these hotels.

Goldman Sachs’s Analyst Steven Kent raised his rating on WYN to “Buy” from “Neutral” and increased his share price target to $26 from $18.

WYN has completed two term securitization transactions involving the issuance of

Vitro Diagnostics Inc. owns various U.S. patents for production of the fertility drug FSH, immortalization of cells, and adult stem cells. The company recently announced the newest addition to its current product lineup, a new serum-free stem cell growth medium.

According to the press release, the new product is a serum-free and animal component-free medium. The product is optimized for human stem-cell growth, and eliminates the risk of exposure to contamination from serum or animal components. Adult stem cells are usually derived from bone marrow, umbilical cord blood, or peripheral blood, which then must be purified to maximize therapeutic benefits. Vitro’s new serum-free stem cell growth medium reduces differentiation and harmful contamination.

Running under the banner, “Harnessing the Power of Cells,” Vitro continues to improve and improve its pipeline of patented adult stem cells and patent-pending technology for stem cell therapy of cancer. Today’s announcement is in line with the company’s